In announcing the Australian Brain Cancer Mission, seven strategic activities were identified for immediate and early implementation.
Enabling Australia participation in GBM (glioblastoma) AGILE
To improve therapy and outcomes for Australian Glioblastoma brain cancer patients through providing access to innovative and new clinical trials with the aim of pursuing research breakthroughs.
Consolidating the ZERO Childhood Cancer initiative as a national clinical trial open to all Australian children diagnosed with high risk brain cancer
To support research activities which enable the provision of a personalised medicine program for all Australian children with high risk brain cancers with the ultimate goal of improving survival outcomes.
Enhancing the capacity of ANZCHOG and COGNO
To improve therapy and outcomes for Australian children and adults with brain cancer through enhancing access to international clinical trials.
Establishing a contestable grants program to support new and expanded clinical trials and international collaborations
To support new and expanded clinical trials and international collaborations in brain cancer.
Auditing national care standards, decision support and clinical pathways for patients
To provide an understanding of the availability and range of current clinical care standards, decision support tools and clinical pathways for patients with brain cancer.
Analysis of Australian brain cancer platforms and technologies
To examine the platforms and technologies that exist to support brain cancer research in Australia.
Initiation of a research program to improve understanding of survivorship
Invest in survivorship research to better understand the lifelong impact of a brain cancer diagnosis.